Startup · $347.6m raised
Brisbane, QLD
Every investor coverage indicates participated in a round Ellume Health raised.
| Investor | Rounds | Invested |
|---|---|---|
| National Institutes of Health | Grant | $42,600,000 |
| Queensland Government | Grant | - |
| U.S. Department of Defense | Grant | $305,000,000 |
| U.S. Government | Grant | $300,000,000 |
Companies Ellume Health acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Ellume Health. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas has begun a phase one trial in Australia of its needle-free COVID-19 vaccine patch. The Brisbane company, backed by OneVentures, Brandon Capital and others, has hired Scott Fry from Ellume as COO.
Brisbane biotech Vaxxas has begun human testing of its microneedle patch for COVID-19 vaccination and plans a phase two study; the venture-backed company has raised over $66 million.
Ellume's Australian operations have entered voluntary administration, with FTI Consulting appointed administrators; the US business continues. The Brisbane diagnostics maker earlier raised $5 million and won a big US government supply contract.
Also Startup Daily
Techboard's March 2022 roundup of Australian funding: megadeals by Immutable, Saluda Medical, Linktree and Zeller, many smaller raises, acquisitions, an IPO, several fund closes, and companies still seeking capital.
Queensland's essential goods grant program has backed ten local manufacturers pivoting to COVID supplies, but applications are paused while Treasury reviews how the allocated money is spent.
Also @AuManufacturing
Brisbane diagnostics company Ellume signed a US government contract worth US$231.8 million to supply Covid-19 home tests and build a US factory, alongside earlier grants from the NIH and Queensland government.
Also SmartCompany·SmartCompany·Startup Daily·@AuManufacturing
Brisbane diagnostics company Ellume wins US emergency authorisation for its COVID-19 home test, backed by an earlier NIH grant and a mid-2020 private raise as it scales production.
Also Startup Daily
Brisbane diagnostics maker Ellume is scaling up COVID-19 test production with Queensland Government backing through its supply chain programme, while Bosch's manufacturing arm automates the high-volume lines.
Roundup of Australian manufacturing briefs: Bosch's automation arm partners with Ellume on COVID-19 test production, Tonga receives an Austal-built patrol boat, Micro-X ships Rover X-ray units, and Envirostream wins a government recycling grant.
Brisbane diagnostics company Ellume has raised $5 million to commercialise its products and prepare for a future ASX listing, though its investors remain undisclosed.
Profile of Ellume, a Queensland diagnostics startup whose founder Dr Sean Parsons describes smartphone flu self-testing, partnerships with GSK and QIAGEN, and a planned ASX float within a year.